LCN2 and metabolic dysfunction-associated steatotic liver disease: In the present study, the knockdown of hepatic NCN2 using a siRNA delivery system resulted in improvement in PCB-induced hepatic steatosis and HIO in vitro models, indicating that LCN2 plays a critical role in PCB-induced NAFLD/NASH.